THE SITE director who steered GlaxoSmithKline’s pharmaceutical manufacturing facility at Montrose through two years of growth and development has been recognised by his industry peers winning a prestigious award sponsored by Scottish Enterprise, the country’s main economic development agency.
Dave Tudor, who led the 250-strong site which makes active ingredients for some of GSK’s most significant products, won the Business Leadership category of Scottish Enterprise’s 2011 Life Sciences Awards.
During Dr Tudor’s spell as site director, the Montrose facility not only made existing manufacturing processes more efficient and introduced new products but also helped GSK respond to world health authorities building stockpiles of a treatment to counter a potential swine flu pandemic.
GSK Montrose is the sole supplier of zanamivir, the active ingredient in GSK’s anti-viral flu treatment Relenza, and its double achievement of restarting manufacture at short notice at the same time as doubling capacity was praised by Alex Salmond, Scottish First Minister, on a visit to the facility.
As well as being sole supplier of a number of key ingredients for GSK’s portfolio of respiratory products, which have annual sales in excess of £5 billion, Montrose is also playing an important role in helping the company expand its dermatological business.
Dr Tudor, who moved to a more senior post within GSK manufacturing last month to lead all of the company’s primary manufacturing sites, said that it had been a pleasure to lead such a positive management team and workforce.
“Whatever the company asks of Montrose, people just get on with it. Everyone rose to a wide range of challenges as the site achieved a £25 million trading improvement moving from operating at a loss to being well in profit.
“Having made great strides in achieving lean manufacturing, GSK Montrose now has ambitious plans to become one of the company’s greenest and most sustainable facilities, including harnessing wind and tidal power to become self-sufficient in electricity and to become carbon neutral.”
Rhona Allison, Director of Life Sciences at Scottish Enterprise, said, “All of the 2011 award winners have been recognised for the valuable contribution they are making to the growth of the sector in Scotland and they should be proud of their success.”
In deciding the winner of the business leadership award the judging panel reported that Dr Tudor was an ambitious leader who had engaged with the GSK Corporate Executive Team at a senior level to raise the profile of GSK Montrose within the group and within Scotland.